Nuvation Bio Inc. NUVB-WT
NUVB-WT
Nuvation Bio Inc. PRTA
Prothena Corporation plc AKBA
Akebia Therapeutics, Inc. ZVRA
Zevra Therapeutics, Inc. CRVS
Corvus Pharmaceuticals, Inc. OLMA
Olema Pharmaceuticals, Inc. NAGE
Niagen Bioscience Inc GOSS
Gossamer Bio, Inc. RIGL
Rigel Pharmaceuticals, Inc. KALV
KalVista Pharmaceuticals, Inc.
Nuvation Bio Inc. PRTA
Prothena Corporation plc AKBA
Akebia Therapeutics, Inc. ZVRA
Zevra Therapeutics, Inc. CRVS
Corvus Pharmaceuticals, Inc. OLMA
Olema Pharmaceuticals, Inc. NAGE
Niagen Bioscience Inc GOSS
Gossamer Bio, Inc. RIGL
Rigel Pharmaceuticals, Inc. KALV
KalVista Pharmaceuticals, Inc.
Performance
| Periode | NUVB-WT | PRTA | AKBA | ZVRA | CRVS | OLMA | NAGE | GOSS | RIGL | KALV |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -65.35 % | 46.38 % | -64.95 % | -29.20 % | 70.44 % | 517.86 % | -43.13 % | 71.03 % | 103.76 % | -0.58 % |
| YTD | -74.90 % | -1.03 % | -12.26 % | 8.57 % | -2.91 % | 12.18 % | 0.82 % | -13.89 % | -7.94 % | -2.45 % |
| 1Y | -63.91 % | -31.39 % | -29.90 % | 13.05 % | 44.46 % | 413.77 % | 9.21 % | 168.22 % | 113.83 % | 91.88 % |
| 3Y | -48.98 % | -83.69 % | 86.30 % | 52.18 % | 703.08 % | 543.08 % | 198.64 % | 16.43 % | 115.14 % | 111.53 % |
| 5Y | -48.98 % | -33.00 % | -55.41 % | 51.93 % | 75.06 % | -32.14 % | 34.93 % | -75.90 % | 2.42 % | -13.27 % |
| 10Y | -48.98 % | -80.13 % | -82.45 % | -96.40 % | -50.12 % | -42.12 % | 68.03 % | -86.18 % | 35.60 % | -57.59 % |
| From the beginning | -48.98 % | 26.46 % | -94.91 % | -94.95 % | -50.12 % | -42.12 % | -46.14 % | -86.18 % | -93.98 % | -80.62 % |